Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

70
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
70
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

102
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
102
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

122
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
122
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

93
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
93
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

64
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
64

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exercise Training in High-Risk Populations: A Scientific Statement From the American Heart Association.

Circulation·2026
Same author

Advancing Cardiogeriatric Care and Frailty Science in Cardiovascular Disease: From Basic Science to Implementation.

Heart, lung & circulation·2026
Same author

Association of deep learning-derived temporalis sarcopenia with mortality in acute ischemic stroke.

The journals of gerontology. Series A, Biological sciences and medical sciences·2026
Same author

Automatic computation of breast cancer biomarkers from multiple [Formula: see text] F-FDG PET image segmentation.

Scientific reports·2026
Same author

Reinforcement Learning for Unsupervised Domain Adaptation in Spatio-Temporal Echocardiography Segmentation.

IEEE transactions on medical imaging·2026
Same author

BundleParc: Consistent white matter bundle parcellation without tractography.

Medical image analysis·2026

Related Experiment Video

Updated: Oct 13, 2025

Retrospective Cardiac Gating with A Prototype Small-Animal X-ray Computed Tomograph
05:32

Retrospective Cardiac Gating with A Prototype Small-Animal X-ray Computed Tomograph

Published on: February 21, 2025

467

Generative Adversarial Networks in Cardiology.

Youssef Skandarani1, Alain Lalande2, Jonathan Afilalo3

  • 1Groupe IFTIM, Laboratoire ImViA, UFR Sciences et Techniques, Université de Bourgogne, Dijon, France.

The Canadian Journal of Cardiology
|November 15, 2021
PubMed
Summary

Generative adversarial networks (GANs) create high-quality synthetic data for cardiology, including realistic cardiac images and health records. These advanced AI models show great potential for research and clinical care, despite ongoing challenges.

More Related Videos

Generation of First Heart Field-like Cardiac Progenitors and Ventricular-like Cardiomyocytes from Human Pluripotent Stem Cells
08:37

Generation of First Heart Field-like Cardiac Progenitors and Ventricular-like Cardiomyocytes from Human Pluripotent Stem Cells

Published on: June 19, 2018

7.1K

Related Experiment Videos

Last Updated: Oct 13, 2025

Retrospective Cardiac Gating with A Prototype Small-Animal X-ray Computed Tomograph
05:32

Retrospective Cardiac Gating with A Prototype Small-Animal X-ray Computed Tomograph

Published on: February 21, 2025

467
Generation of First Heart Field-like Cardiac Progenitors and Ventricular-like Cardiomyocytes from Human Pluripotent Stem Cells
08:37

Generation of First Heart Field-like Cardiac Progenitors and Ventricular-like Cardiomyocytes from Human Pluripotent Stem Cells

Published on: June 19, 2018

7.1K

Area of Science:

  • Artificial Intelligence
  • Machine Learning
  • Medical Imaging

Background:

  • Generative adversarial networks (GANs) are advanced neural network models.
  • GANs significantly enhance synthetic data quality, establishing them as a standard for data generation.
  • Applications in cardiology are rapidly expanding.

Purpose of the Study:

  • To summarize GAN applications in cardiology.
  • To discuss the utility of GAN-generated data in research, clinical care, and academia.
  • To present examples of GAN-generated cardiac imaging and explore future potential.

Main Methods:

  • Review of GAN applications in cardiology.
  • Generation and presentation of synthetic cardiac magnetic resonance and echocardiography images using 6 different GAN models.
  • Discussion of GAN utility, future applications, and challenges.

Main Results:

  • GANs generate highly realistic synthetic cardiac images, electrocardiography signals, and electronic health records.
  • Image quality of GAN-generated cardiac magnetic resonance and echocardiography has evolved, becoming nearly indistinguishable from real images.
  • GAN-generated data demonstrates utility across research, clinical care, and academic settings.

Conclusions:

  • GANs offer significant potential for advancing cardiology through realistic data synthesis.
  • Future applications include modality translation and patient trajectory modeling.
  • Challenges in training dynamics, medical fidelity, and ethical considerations must be addressed for clinical integration.